Can Clinical Guidelines Afford to Ignore Cost Effectiveness? An Ethical Perspective

被引：0

|

作者：

Kenneth Boyd

Peter Hall

机构：

来源：

PharmacoEconomics | 2016年 / 34卷

关键词：

Everolimus; Moral Responsibility; Pertuzumab; Judicial Review; Eribulin;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：529 / 531

页数：2

相关论文

共 50 条

[21] The role of attention in affordance effects: can we afford to ignore it?
Kostov, Kiril
Janyan, Armina
COGNITIVE PROCESSING, 2012, 13 : S45 - S45
[22] Contemporary role of lymphoscintigraphy: we can no longer afford to ignore!
Lee, B. B.
Laredo, J.
PHLEBOLOGY, 2011, 26 (05) : 177 - 178
[23] Can clinical practice guidelines increase the cost-effectiveness of geriatric rehabilitation?
Stason, WB
MEDICAL CARE, 1997, 35 (06) : JS68 - JS77
[24] The role of attention in the affordance effect: can we afford to ignore it?
Kostov, Kiril
Janyan, Armina
COGNITIVE PROCESSING, 2012, 13 : S215 - S218
[25] Guidelines? Nice if you can afford it
Reynolds, Paul. N. N.
RESPIROLOGY, 2023, 28 (02) : 189 - 189
[26] Customer relationship management: A strategy manufacturers can't afford to ignore
Matthews, L
CONTROL SOLUTIONS, 2001, 74 (08): : 40 - +
[27] Customer relationship management: A strategy manufacturers can't afford to ignore
Matthews, L.
Control Solutions, 2001, 74 (08): : 40 - 45
[28] Can we afford it? Considerations in the cost-effectiveness of managing early CKD
Vale, Luke
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 52 - 52
[29] The origin of acquired immune deficiency syndrome: can science afford to ignore it?
Cribb, J
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 2001, 356 (1410) : 935 - 938
[30] Borderline Rejection in Early Protocol Biopsies: Can We Afford To Ignore It?
Stevens, K.
Fisher, J.
Marsh, C.
Schaffer, R.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 323 - 323

← 1 2 3 4 5 →